Cloudbreak Pharma Inc. (CLOUDBREAK-B) has released its notice of Annual General Meeting, scheduling the session for 26 June 2026 at 09:30 a.m. Hong Kong Time (25 June 2026 at 06:30 p.m. PDT) at 8921 Research Drive, Irvine, California. Key agenda items follow:

1. Financial Statements • Shareholders will be asked to receive and approve the audited consolidated financial statements and the reports of directors and auditors for the financial year ended 31 December 2025.

2. Board Composition • Re-election of Executive Director Mr. Dinh Son Van. • Re-election of Independent Non-executive Directors Mr. Ma Yiu Ho Peter and Mr. Lee Alex Jao Jang. • Board remuneration to be fixed by directors upon shareholder authorisation.

3. Auditor Appointment • HLB Hodgson Impey Cheng Limited is nominated for re-appointment, with remuneration to be determined by the Board.

4. Share Capital Mandates • General mandate authorising the Board to issue, allot, or deal with additional shares—or securities convertible into shares—up to 20 % of issued share capital (excluding treasury shares) during the mandate period. • Separate mandate permits repurchase of shares on the Hong Kong Stock Exchange or other recognised exchanges up to 10 % of issued share capital (excluding treasury shares). • A further resolution allows any repurchased shares to be added to the share issuance limit, effectively extending the issuance capacity by up to an additional 10 %.

5. Administrative Details • Share register will be closed from 23 June 2026 to 26 June 2026 inclusive; transfers must be lodged by 4:30 p.m. on 22 June 2026 to qualify for AGM attendance and voting. • Proxy forms must be submitted to Tricor Investor Services Limited by 09:30 a.m. on 24 June 2026, at least 48 hours before the AGM. • Voting on all resolutions will be conducted by poll in compliance with Hong Kong Listing Rules.

As of the notice date (22 May 2026), the Board comprises three executive directors, three non-executive directors and three independent non-executive directors.